| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nephrol Dial Transplant (2001) 16: 1-4
© 2001 European Renal Association-European Dialysis and Transplant Association
Editorial Comments
How well do we manage and support patients and families with dominantly inherited renal disease?
Unité 535 Inserm, Génétique épidémiologique et structure des populations humaines. Bâtiment Inserm Gregory Pincus, Le Kremlin Bicêtre, France
Introduction
Diagnosis of an inherited disease in an individual affects every member of the family. Consequently, the disease should be viewed as a family issue, not an individual one. However, the care of a person with chronic renal disease places a heavy demand on an overburdened health care system ill equipped to address secondary issues involving unaffected family members. Personal experience with support issues was explored during interviews with patients presenting with Alport syndrome (AS) [1], von HippelLindau (VHL) disease [2], and autosomal dominant polycystic kidney disease (ADPKD) (Levy, unpublished data), and within a patient organization for genetic renal diseases.
The interviews revealed that most patients carry a substantial burden of stress, related not only to the chronic renal disease itself, but also to the fear of discrimination based on genetic risk (health care, insurance, employment), difficulties in their intimate relationships (marital conflict, separation, or familial breakup),
The shock of the announcement
Distressing presymptomatic genetic testing
The particular case of presymptomatic ultrasonography in ADPKD
The anxious uncertainty of children's health status
Particular difficulties with at-risk adolescents
Distress about future children
Conclusion
Acknowledgments
Notes
References
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Ruiz-Ortega, O. Lorenzo, M. Ruperez, V. Esteban, Y. Suzuki, S. Mezzano, J.J. Plaza, and J. Egido Role of the Renin-Angiotensin System in Vascular Diseases: Expanding the Field Hypertension, December 1, 2001; 38(6): 1382 - 1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. MARGETTS, M. KOLB, T. GALT, C. M. HOFF, T. R. SHOCKLEY, and J. GAULDIE Gene Transfer of Transforming Growth Factor-{beta}1 to the Rat Peritoneum: Effects on Membrane Function J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2029 - 2039. [Abstract] [Full Text] [PDF] |
||||

